Aptimmune
Chemicals & Related Products · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1234 Hanley Industrial Ct, St. Louis, Mi...Phone Number
(314) 736-4488Website
www.aptimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aptimmune
Aptimmune Biologics specializes in advanced mucosal vaccines aimed at combating significant swine diseases, including the Porcine Reproductive and Respiratory Syndrome virus and Swine Influenza A virus. Utilizing their innovative Barricade platform technology, they provide solutions for stakeholders in various regions. The company is also engaged in research and development for vaccines targeting the African Swine Fever virus. Their products and services are intended for clients in the swine industry, focusing on enhancing disease protection and improving animal health.Explore more
Aptimmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Aptimmune has new funding data
Check if Aptimmune has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aptimmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Aptimmune
Click to see if Aptimmune had a recent Job posting/layoffs
Aptimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aptimmune launches new products
Check out if Aptimmune is spiking on competitors!
Recommended Actions
Find VP level buyers at Aptimmune
Find 2 more new buyers
Compare Similar Companies to Aptimmune
Compare insights from companies similar to Aptimmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aptimmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aptimmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aptimmune.
Aptimmune financials insights
Gather financial insights about Aptimmune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$2.4M
2017
Series A
$2.2M
2018
Series B
$6M
Aptimmune Tech Stack
A closer look at the technologies used by Aptimmune
Aptimmune News & Media
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptimmune
Sign Up For FreeTo access detailed company insights
Aptimmune Biologics specializes in advanced mucosal vaccines aimed at combating significant swine diseases, including the Porcine Reproductive and Respiratory Syndrome virus and Swine Influenza A virus. Utilizing their innovative Barricade platform technology, they provide solutions for stakeholders in various regions. The company is also engaged i... Read More
